These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21621981)

  • 1. On the clinical implications of β-lactam-aminoglycoside synergism.
    Espino-Hernández M
    Int J Antimicrob Agents; 2011 Aug; 38(2):185-6; author reply 186. PubMed ID: 21621981
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical implications of β-lactam-aminoglycoside synergism: systematic review of randomised trials.
    Marcus R; Paul M; Elphick H; Leibovici L
    Int J Antimicrob Agents; 2011 Jun; 37(6):491-503. PubMed ID: 21292449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta-lactams with or without aminoglycosides.
    Alfandari S; Boussekey N
    Clin Infect Dis; 2005 Nov; 41(10):1542-3; author reply 1543-4. PubMed ID: 16231273
    [No Abstract]   [Full Text] [Related]  

  • 4. [In-vitro synergism between beta-lactam antibiotics and aminoglycoside antibiotics in Pseudomonas, Proteus and Klebsiella (proceedings)].
    Schassan HH
    Zentralbl Bakteriol Orig A; 1976 Aug; 235(1-3):329-37. PubMed ID: 824893
    [No Abstract]   [Full Text] [Related]  

  • 5. Beta-lactam/aminoglycoside combinations: interactions and their mechanisms.
    Moellering RC; Eliopoulos GM; Allan JD
    Am J Med; 1986 May; 80(5C):30-4. PubMed ID: 3717186
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bactericidal synergism between beta-lactams and aminoglycosides: mechanism and possible therapeutic implications.
    Davis BD
    Rev Infect Dis; 1982; 4(2):237-45. PubMed ID: 7051225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. New aac(6')-I genes in Enterococcus hirae and Enterococcus durans: effect on {beta}-lactam/aminoglycoside synergy.
    Del Campo R; Galán JC; Tenorio C; Ruiz-Garbajosa P; Zarazaga M; Torres C; Baquero F
    J Antimicrob Chemother; 2005 Jun; 55(6):1053-5. PubMed ID: 15849260
    [No Abstract]   [Full Text] [Related]  

  • 8. Aminoglycoside/beta-lactam combinations in clinical practice.
    Leibovici L; Paul M
    J Antimicrob Chemother; 2007 Nov; 60(5):911-2. PubMed ID: 17890282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of aminoglycoside and beta-lactam combination therapy versus beta-lactam monotherapy on the emergence of antimicrobial resistance: a meta-analysis of randomized, controlled trials.
    Bliziotis IA; Samonis G; Vardakas KZ; Chrysanthopoulou S; Falagas ME
    Clin Infect Dis; 2005 Jul; 41(2):149-58. PubMed ID: 15983909
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A comparative review of combination therapy: 2 beta-lactams versus beta-lactam plus aminoglycoside].
    Dejace P; Klastersky J
    Infection; 1987; 15 Suppl 4():S158-67. PubMed ID: 3312028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro activities of beta-lactam and aminoglycoside antibiotics. A comparative study of 20 parenterally administered drugs.
    Fass RJ
    Arch Intern Med; 1980 Jun; 140(6):763-8. PubMed ID: 7387270
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro synergistic activity of colistin with aminoglycosides, beta-lactams and rifampin against multidrug-resistant gram-negative bacteria.
    Chitnis S; Chitnis V; Chitnis DS
    J Chemother; 2007 Apr; 19(2):226-9. PubMed ID: 17434834
    [No Abstract]   [Full Text] [Related]  

  • 13. [Study of "in vitro" susceptibility of "Mycobacterium fortuitum" to aminoglycoside and beta-lactam antibiotics (author's transl)].
    Casal M; Rodriguez F
    Ann Microbiol (Paris); 1981; 132B(1):51-6. PubMed ID: 7305191
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Collateral sensitivity between aminoglycosides and beta-lactam antibiotics depends on active proton pumps.
    Azimi L; Rastegar Lari A
    Microb Pathog; 2017 Nov; 112():122-125. PubMed ID: 28958949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-lactam and aminoglycoside resistance rates and mechanisms among Pseudomonas aeruginosa in French general practice (community and private healthcare centres).
    Dubois V; Arpin C; Dupart V; Scavelli A; Coulange L; André C; Fischer I; Grobost F; Brochet JP; Lagrange I; Dutilh B; Jullin J; Noury P; Larribet G; Quentin C
    J Antimicrob Chemother; 2008 Aug; 62(2):316-23. PubMed ID: 18467306
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Part V. Other beta-lactam antimicrobials.
    Gibbs WJ; Cooper TW; Bronze MS; Greenfield RA
    J Okla State Med Assoc; 2007 Jan; 100(1):23-5. PubMed ID: 17378498
    [No Abstract]   [Full Text] [Related]  

  • 17. Aminoglycoside drugs in clinical practice: an evidence-based approach.
    Leibovici L; Vidal L; Paul M
    J Antimicrob Chemother; 2009 Feb; 63(2):246-51. PubMed ID: 19022778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The mechanism of action of 2 major families of antibiotics: beta-lactams and aminoglycosides. Practical consequences].
    Michel-Briand Y
    Ann Anesthesiol Fr; 1979; 20(6-7):571-6. PubMed ID: 95083
    [No Abstract]   [Full Text] [Related]  

  • 19. [Beta-lactam and aminoglycoside resistant phenotypes in enterobacteria isolated in pediatrics].
    Ben Hassen A; Chourou O; Fendri C; Kammoun A; Ben Redjeb S
    Bull Soc Pathol Exot; 1991; 84(2):145-53. PubMed ID: 1914045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sensitivity to beta-lactams and aminoglycosides of clinically important pathogens isolated from children in Poland.
    Dzierzanowska D; Kamińska W
    J Chemother; 1989 Jul; 1(4 Suppl):366-7. PubMed ID: 16312442
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.